A Trial of Adjunctive Prednisolone and Mycobacterium w Immunotherapy in Tuberculous Pericarditis

clinical trial

Details

Instance of: clinical trial
Start time: December 2008
End time: February 2014
Country: South Africa
Main subject: pericarditis, tuberculosis
clinical trial phase: phase III clinical trial
minimum age: 18
number of participants: 1400
research intervention: prednisolone, methylprednisolone, prednisolone acetate, methylprednisolone hemisuccinate, prednisolone 21-phosphate, immunologic factor
short name: IMPI
study type: interventional study
title: A Trial of Adjunctive Prednisolone and Mycobacterium w Immunotherapy in Tuberculous Pericarditis

Nothing in the MetaHistoryBook collection references this item yet.